IP84-21: COL2A1 as a Novel Therapeutic Target in High-Risk Wilms Tumor

IP84-21: COL2A1 as a Novel Therapeutic Target in High-Risk Wilms Tumor

Monday, May 18, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)

147B

Abstract

Sessions

IP84: Kidney Cancer: Basic Research & Pathophysiology

Monday, May 18, 2026 9:30 AM to 11:30 AM

Log in

See all the content and easy-to-use features by logging in or registering!